Financials
- Market Capitalization 25.01 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.vynetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00H5W8GM8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
—
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4550 | NXTC NextCure, Inc. - Common Stock | 5.67 USD | -13.83% | +196.86% | +175.24% | -56.72% | 20.48 M USD | ||
| 4551 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.70 USD | -4.11% | -1.41% | +1.45% | -66.18% | 22.79 M USD | ||
| 4582 | CELU Celularity Inc. - Class A Common Stock | 0.75 USD | -1.32% | -1.32% | -3.85% | -64.95% | 21.71 M USD | ||
| 4586 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.41 USD | -0.45% | +2.92% | -6.22% | +129.23% | 21.71 M USD |